unleashing the Power of Artificial Intelligence for Personalised Drug Design

Precision medicine holds the promise of personalised treatment based on an individual's genetic makeup. However, the lengthy and costly process of drug discovery hinders progress. Can artificial intelligence (AI), specifi-cally generative models offer a solution? Is it possible to ef-ficiently select the most promising drug candidates for val-idation? Our research focuses on developing robust tools that streamline the validation process of drug design - sav -ing time and resources.